Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

1.

Psst, Have I Got a Model for You . . .

Caro JJ.

Med Decis Making. 2014 Nov 20. pii: 0272989X14559729. [Epub ahead of print] No abstract available.

PMID:
25413367
[PubMed - as supplied by publisher]
2.

Decision-analytic models: current methodological challenges.

Caro JJ, Möller J.

Pharmacoeconomics. 2014 Oct;32(10):943-50. doi: 10.1007/s40273-014-0183-5.

PMID:
24986039
[PubMed - in process]
3.

COMMUNICATING THE PARAMETER UNCERTAINTY IN THE IQWiG EFFICIENCY FRONTIER TO DECISION-MAKERS.

Stollenwerk B, Lhachimi SK, Briggs A, Fenwick E, Caro JJ, Siebert U, Danner M, Gerber-Grote A.

Health Econ. 2014 Mar 4. doi: 10.1002/hec.3041. [Epub ahead of print]

PMID:
24590819
[PubMed - as supplied by publisher]
4.

Use of relative effectiveness information in reimbursement and pricing decisions in Europe.

van Nooten F, Caro JJ.

J Comp Eff Res. 2013 Jan;2(1):33-44. doi: 10.2217/cer.12.71.

PMID:
24236519
[PubMed - indexed for MEDLINE]
5.

ISPOR-SMDM task force's recommendations for good modeling practices-reply to letter to the editor by Corro Ramos.

Caro JJ, Eddy DM, Hollingworth W, Tsevat J, McDonald KM, Wong JB, Briggs AH, Siebert U, Kuntz KM.

Value Health. 2013 Sep-Oct;16(6):1108. doi: 10.1016/j.jval.2013.06.016. No abstract available.

PMID:
24041365
[PubMed - indexed for MEDLINE]
6.

Lopinavir/ritonavir versus darunavir plus ritonavir for HIV infection: a cost-effectiveness analysis for the United States.

Simpson KN, Pei PP, Möller J, Baran RW, Dietz B, Woodward W, Migliaccio-Walle K, Caro JJ.

Pharmacoeconomics. 2013 May;31(5):427-44. doi: 10.1007/s40273-013-0048-3.

PMID:
23620210
[PubMed - indexed for MEDLINE]
7.

How relevant is cost-effectiveness anyway?

Caro JJ.

Eur Heart J. 2013 Jan;34(4):245-6. No abstract available.

PMID:
23457725
[PubMed - indexed for MEDLINE]
Free Article
8.

Medical planning and response for a nuclear detonation: a practical guide.

Coleman CN, Adams S, Adrianopoli C, Ansari A, Bader JL, Buddemeier B, Caro JJ, Casagrande R, Case C Jr, Caspary K, Chang AS, Chang HF, Chao N, Cliffer KD, Confer D, Deitchman S, Derenzo EG, Dobbs A, Dodgen D, Donnelly EH, Gorman S, Grace MB, Hatchett R, Hick JL, Hrdina C, Jones R, Kane E, Knebel A, Koerner JF, Laffan AM, Larson L, Livinski A, Mackinney J, Maidment BW, Manning R, Marinissen MJ, Martin C, Michael G, Murrain-Hill P, Nemhauser JB, Norwood AE, Nystrom S, Raheem M, Redlener I, Sheehan K, Simon SL, Taylor TP, Toner E, Wallace KS, Wieder J, Weinstock DM, Wiley AL Jr, Yeskey K, Miller CW, Whitcomb RC Jr.

Biosecur Bioterror. 2012 Dec;10(4):346-71. doi: 10.1089/bsp.2012.1025. Erratum in: Biosecur Bioterror. 2013 Mar;11(11):88. Miller, Charles W [added]; Whitcomb, Robert C Jr [added].

PMID:
23244500
[PubMed - indexed for MEDLINE]
9.

User-managed inventory: an approach to forward-deployment of urgently needed medical countermeasures for mass-casualty and terrorism incidents.

Coleman CN, Hrdina C, Casagrande R, Cliffer KD, Mansoura MK, Nystrom S, Hatchett R, Caro JJ, Knebel AR, Wallace KS, Adams SA.

Disaster Med Public Health Prep. 2012 Dec;6(4):408-14. doi: 10.1001/dmp.2012.46a.

PMID:
23241473
[PubMed - indexed for MEDLINE]
10.

How cost-effective are drugs and devices used in cardiology?

Caro JJ.

Eur Heart J. 2012 Oct;33(19):2372-3. No abstract available.

PMID:
23198294
[PubMed - indexed for MEDLINE]
Free Article
11.

Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7.

Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB; ISPOR−SMDM Modeling Good Research Practices Task Force.

Value Health. 2012 Sep-Oct;15(6):843-50. doi: 10.1016/j.jval.2012.04.012.

PMID:
22999134
[PubMed - indexed for MEDLINE]
12.

Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4.

Karnon J, Stahl J, Brennan A, Caro JJ, Mar J, Möller J; ISPOR-SMDM Modeling Good Research Practices Task Force.

Value Health. 2012 Sep-Oct;15(6):821-7. doi: 10.1016/j.jval.2012.04.013.

PMID:
22999131
[PubMed - indexed for MEDLINE]
13.

Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.

Caro JJ, Briggs AH, Siebert U, Kuntz KM; ISPOR-SMDM Modeling Good Research Practices Task Force.

Value Health. 2012 Sep-Oct;15(6):796-803. doi: 10.1016/j.jval.2012.06.012.

PMID:
22999128
[PubMed - indexed for MEDLINE]
14.

Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7.

Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB; ISPOR-SMDM Modeling Good Research Practices Task Force.

Med Decis Making. 2012 Sep-Oct;32(5):733-43.

PMID:
22990088
[PubMed - indexed for MEDLINE]
15.

Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4.

Karnon J, Stahl J, Brennan A, Caro JJ, Mar J, Möller J.

Med Decis Making. 2012 Sep-Oct;32(5):701-11.

PMID:
22990085
[PubMed - indexed for MEDLINE]
16.

Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1.

Caro JJ, Briggs AH, Siebert U, Kuntz KM; ISPOR-SMDM Modeling Good Research Practices Task Force.

Med Decis Making. 2012 Sep-Oct;32(5):667-77. Review.

PMID:
22990082
[PubMed - indexed for MEDLINE]
17.

Optimizing the design of pragmatic trials: key issues remain.

Caro JJ, Ishak KJ.

J Comp Eff Res. 2012 Jul;1(4):319-27. doi: 10.2217/cer.12.37. Review.

PMID:
24237466
[PubMed - indexed for MEDLINE]
18.

Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myeloma.

Ishak KJ, Caro JJ, Drayson MT, Dimopoulos M, Weber D, Augustson B, Child JA, Knight R, Iqbal G, Dunn J, Shearer A, Morgan G.

Value Health. 2011 Jul-Aug;14(5):672-8. doi: 10.1016/j.jval.2011.02.1182.

PMID:
21839405
[PubMed - indexed for MEDLINE]
19.

Unaltered ethical standards for individual physicians in the face of drastically reduced resources resulting from an improvised nuclear device event.

Caro JJ, Coleman CN, Knebel A, DeRenzo EG.

J Clin Ethics. 2011 Spring;22(1):33-41.

PMID:
21595353
[PubMed - indexed for MEDLINE]
20.

Economic evaluation of clopidogrel plus aspirin for secondary prevention of cardiovascular events in Canada for patients with established cardiovascular disease: Results from the CHARISMA trial.

Chen J, Shi C, Mahoney EM, Dunn ES, Rinfret S, Caro JJ, O'Brien J, El-Hadi W, Bhatt DL, Topol EJ, Cohen DJ.

Can J Cardiol. 2011 Mar-Apr;27(2):222-31. doi: 10.1016/j.cjca.2010.12.021.

PMID:
21459271
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk